ARB Corporation Shares (ASX:ARB) On An Impressive Rally, When To Apply The Brakes?
ARB Corporation shares (ASX:ARB) were down 1.74% today at market close, but it’s YTD remains rather more impressive, sitting at 11.71%. With a 52 week high of $41.83 and price at close today of $40.17, this one is trading close to the top end of its’ previous range. Looking over a slightly longer timeframe, ARB…
Cann Group Change Of CEO – Still Delisted
Cann Group Limited (ASX:CAN) who were delisted earlier this year, and suspended from trading announced a significant shift in its executive team as CEO Peter Koetsier resigned recently, citing personal “family reasons” for his departure. The Melbourne-based cannabis company is positioning itself for a new strategic direction amidst a consolidation of its operations and financial…
All Ords Shed 1.38% On A Red Day : Latest From Markets
CBA shares closed down 1.88% today on a tough day for Aussie bank stocks and the markets generally. The ASX200 dropped 1.34% whilst the All Ords shed 1.38% as some of the spill over from the broader market pullback seen yesterday in international markets touched down at home. In the U.S. financial markets this Tuesday,…
Westpac shares (ASX: WBC) down 1.07% today – analysts differ from sentiment
Westpac shares (ASX: WBC) ended the day firmly in the red, 1.07% down as the Aussie bank stocks and the markets generally pulled back to start Q2. Taking a closer look at Westpac reveals some interesting numbers and forecasts. Riding the wave of a 11.92% increase since the start of the year, Westpac Banking Corp…
US Markets In 2024 – Strong Q1 Winners, What Next?
Stocks took a plunge on Monday, with the Dow Jones Industrial Average shedding 264 points or 0.7%, as market participants braced themselves for a potentially tighter monetary policy landscape. Tuesday has started the early part of trading in similar fashion, with the DJIA shedding more than 1% in early trading, as the S&P 500, Nasdaq…
What are Australian Clinical Labs (ASX:ACL) Growth Prospects?
Australian Clinical Labs Limited shares (ASX:ACL) have become a point of interest for investors as it has demonstrated a robust share price growth of 7.60% on the ASX over the past month. This performance sparks an inquiry: is it too late to consider buying ACL shares, or does this growth foreshadow a promising future for…
Lynas Rare Earth Shares (ASX: LYC) Down 20.64% YTD, But Why?
Lynas Rare Earths Limited (ASX:LYC) shares are down 20.64% YTD, and compared to some of its’ industry peers has a rather uncommon shareholder composition that may impact volatility to some respect. For a company of its size, LYC finds itself majorly owned by individual retail investors, who hold a commanding 53% of the company’s shares….
Why Is (ASX: PLS) Pilbara Minerals Share Price Dropping?
In the turbulent tides of the markets, Pilbara Minerals Limited (ASX: PLS) share price is currently weathering a downturn with its share price experiencing an 13.15% slip over the past month. This decline might disconcert investors at a glance, but a deep dive into the company’s fundamental financial health indicates this may be little more…
QBE Insurance Group Ltd (ASX:QBE) Stellar Performance and Bumper Dividend Payouts
QBE Insurance Group (ASX:QBE) has emerged with a gleaming report card, boasting a significant upswing in its net income to US$1.355 billion for the year ended December 31, 2023. As a reward to its shareholders, QBE upped its final dividend to A$0.48 per share for 2023, likely stirring the interest of yield-hungry investors. QBE closed…
ASX200 Evening Roundup
The Australian stock market capped off an extraordinary week, with the ASX 200 soaring to set a new record, reflecting a surge of unrestrained demand from investors. The benchmark index firmly concluded the trading session on a high note, advancing 77.3 points or gaining 0.99% to establish a fresh record. In what has been an…
